UKPDS Risk Engine, DECODE and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes

Current Diabetes Reviews

Volumn 6, Issue 1, 2010, Pages 1-8

  Almeda Valdes, Paloma ^a   Cuevas Ramos, Daniel ^a   Mehta, Roopa ^a   Gomez Perez, Francisco J ^a   Aguilar Salinas, Carlos A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cardiovascular risk; DECODE; Diabetes mellitus; Diabetes PHD; UKPDS risk engine

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL;

ALGORITHM; ANGINA PECTORIS; AREA UNDER THE CURVE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLUSTER ANALYSIS; COHORT ANALYSIS; DECISION MAKING; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SIMULATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FATALITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HEALTH CARE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; INDEPENDENT VARIABLE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIFE EXPECTANCY; LIPID PEROXIDATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEARCH ENGINE; SENSITIVITY AND SPECIFICITY; SEX RATIO; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ULCER; VISION; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; COMPUTER SIMULATION; DECISION MAKING; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; RISK ASSESSMENT;

EID: 77950829125     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339910790442646     Document Type: Review

References (29)

1. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007; 167: 1145-1151 (Pubitemid 46924742)
2. Vilbergsson S, Sigurdsson G, Sigvaldason H, Sifgfusson N. Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17 year follow up. J Intern Med 1998; 244: 30916. (Pubitemid 28473994)
3. Bierman EL. George Lyman duff memorial lecture. Atherogenesis in diabetes. Arterioscler Thromb 1992; 12: 647-656
4. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234 (Pubitemid 28350165)
5. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765-775 (Pubitemid 47263159)
6. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823-828 (Pubitemid 28112428)
7. Fonseca V, Desouza C, Asnani S, Jialal I. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev 2004; 25: 153-175 (Pubitemid 38269978)
8. Nicolucci A, De Berardis G, Sacco M, Tognoni G. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from de American Heart Association and the American Diabetes Association: response to Buse et al. Diabetes Care 2007; 30: 162-172 (Pubitemid 46871210)
9. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999; 100: 1132-1133 (Pubitemid 29416242)
10. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115: 114-126 (Pubitemid 46058619)
11. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-1172 (Pubitemid 28368527)
12. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender Difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 24: 2898-2904 (Pubitemid 39565056)
13. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 223-240 (Pubitemid 29056916)
14. Natarajan S, Liao Y, Sinha D, Cao G, McGee DL, Lipsitz SR. Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 2005; 165: 430-435 (Pubitemid 40280199)
15. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002; 162: 1737-1745
16. Balkau B, Hu G, Qiao Q, et al. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004; 47: 2118-2128 (Pubitemid 40174684)
17. The DECODE study group. Euroean Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621
18. Mount Hood 4 Modeling Group. Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting. Diabetes Care 2007; 30: 1638-1646
19. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
20. Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci 2001; 101: 671-679 (Pubitemid 33135349)
21. Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004; 47: 1747-1759 (Pubitemid 40022410)
22. Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care 2003; 26: 3093-3101 (Pubitemid 37339504)
23. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-126
24. Guzder RN, Gatling W, Mullee MA, Merita RL, Byrne CD. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabet Med 2005; 22: 554-562 (Pubitemid 40593130)
25. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. (Pubitemid 36712275)
26. Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 Diabetes. Diabetes Care 2007; 30: 1292-1293 (Pubitemid 46684668)
27. Simmons RK, Coleman RL, Price HC, et al. Performance of the UK prospective diabetes study risk engine and the framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk Cohort. Diabetes Care 2009; 32: 708-713
28. Hall LM, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 2003; 326: 251-252 (Pubitemid 36169586)
29. Bloomgarden ZT. American Diabetes Association 60th Scientific Sessions, 2000: cardiovascular disease in diabetes. Diabetes Care 2001; 24: 399-404. (Pubitemid 32119145)